EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Availability of multidisciplinary treatment modalities and outcomes among patients with resected early-stage non-small cell lung cancer

Brendan T Heiden iD, Daniel B Eaton iD, Jatinder Palta iD, Su-Hsin Chang iD, Yan Yan, Ana A Baumann iD, Theodore S Thomas, Martin W Schoen iD, Steven Tohmasi iD, Nikki Rossetti iD, Mayank R Patel iD, Daniel Kreisel und 5 weitere

JNCI Cancer Spectrum · 03.11.2025 · 9 (6)

DOI: 10.1093/jncics/pkaf104 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI Cancer Spectrum, online erschienen am 31.10.2025. Verfasst von Brendan T Heiden und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, MO, United States. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Radiosurgery, Pneumonectomy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: United States Department of Veterans Affairs, NIH HHS, VA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Comprehensive, multidisciplinary care is crucial for managing early-stage non-small cell lung cancer (NSCLC), typically treated via lung resection or stereotactic body radiation therapy (SBRT). We evaluated how variable access to on-site SBRT may be associated with clinical outcomes for patients with stage I NSCLC receiving surgical resection within an integrated health-care system.

Methods

We performed a retrospective cohort study of patients with stage I NSCLC treated with lung resection at Veterans Health Administration (VHA) facilities between 2006 and 2016. The VHA provides thoracic surgery at approximately 100 facilities, whereas lung SBRT is currently available at approximately 20 facilities. We compared short- and long-term outcomes for patients treated at surgery-only facilities vs those at facilities offering surgery and SBRT.

Results

We identified 6289 patients undergoing lung resection, with 4673 (74.3%) treated at surgery-only sites and 1616 (25.7%) at surgery + SBRT sites. Sociodemographic factors were similar between cohorts. Surgery + SBRT sites showed higher adherence to operative quality metrics and improved patient selection. Short-term outcomes were better at surgery + SBRT sites with lower rates of 30-day major complications, 30-day mortality, and 90-day mortality. With a median follow-up of 6.3 years, 5-year overall survival was higher at surgery + SBRT sites (59.4% vs 56.9%; adjusted hazard ratio 1.12, 95% CI = 1.02 to 1.23).

Conclusion

Short- and long-term outcomes were better for patients with stage I NSCLC who underwent lung resection at facilities delivering thoracic surgery and SBRT. These findings support recommendations to increase SBRT availability at medical centers offering lung resection to ensure comprehensive multidisciplinary care is provided.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsRadiosurgeryPneumonectomyHealth Services AccessibilityHumansMaleFemaleRetrospective StudiesAgedMiddle AgedTreatment OutcomeNeoplasm StagingUnited StatesUnited States Department of Veterans AffairsCombined Modality TherapyAged, 80 and over

Autor:innen und Institutionen

  • Division of Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, MO, United States.
  • VA St Louis Health Care System, St. Louis, MO, United States.
  • National Radiation Oncology Program, Veterans Health Administration, Washington, DC, United States.
  • Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, MO, United States.
  • Division of Oncology, Washington University School of Medicine, St. Louis, MO, United States.
  • Division of Hematology and Medical Oncology, Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, MO, United States.

ORCID-Profile: Brendan T Heiden, Daniel B Eaton, Jatinder Palta, Su-Hsin Chang, Ana A Baumann, Martin W Schoen, Steven Tohmasi, Nikki Rossetti, Mayank R Patel, Ruben G Nava, Bryan F Meyers, Drew Moghanaki

Förderung

  • United States Department of Veterans Affairs
  • NIH HHS
  • VA
  • HSRD VA
  • Stanley Iezman and Nancy Stark Endowment for Thoracic Radiation Oncology Research
  • NHLBI NIH HHS
  • NCI NIH HHS
  • National Institutes of Health

Zitieren

APA

Heiden, B. T., Eaton, D. B., Palta, J., Chang, S. H., Yan, Y., Baumann, A. A., Thomas, T. S., Schoen, M. W., Tohmasi, S., Rossetti, N., Patel, M. R., Kreisel, D., Nava, R. G., Meyers, B. F., Kozower, B. D., Puri, V., & Moghanaki, D. (2025). Availability of multidisciplinary treatment modalities and outcomes among patients with resected early-stage non-small cell lung cancer. JNCI Cancer Spectrum, 9(6). https://doi.org/10.1093/jncics/pkaf104

Vancouver

Heiden BT, Eaton DB, Palta J, Chang SH, Yan Y, Baumann AA, et al. Availability of multidisciplinary treatment modalities and outcomes among patients with resected early-stage non-small cell lung cancer. JNCI Cancer Spectrum. 2025;9(6). doi:10.1093/jncics/pkaf104

BibTeX
@article{Heiden2025,
  author = {Heiden, Brendan T and Eaton, Daniel B and Palta, Jatinder and Chang, Su-Hsin and Yan, Yan and Baumann, Ana A and Thomas, Theodore S and Schoen, Martin W and Tohmasi, Steven and Rossetti, Nikki and Patel, Mayank R and Kreisel, Daniel and Nava, Ruben G and Meyers, Bryan F and Kozower, Benjamin D and Puri, Varun and Moghanaki, Drew},
  title = {Availability of multidisciplinary treatment modalities and outcomes among patients with resected early-stage non-small cell lung cancer},
  journal = {JNCI Cancer Spectrum},
  year = {2025},
  volume = {9},
  number = {6},
  doi = {10.1093/jncics/pkaf104}
}
Kostenlos starten →